Imricor Medical Systems, Inc. (ASX:IMR)
Australia
· Delayed Price · Currency is AUD 1.395
+0.015 (1.09%)
At close: Dec 5, 2025
Imricor Medical Systems Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Revenue | 0.75 | 0.96 | 0.62 | 0.82 | 0.7 | 0.7 | Upgrade
|
| Revenue Growth (YoY) | -9.19% | 55.86% | -24.56% | 17.20% | -0.84% | 9.76% | Upgrade
|
| Cost of Revenue | 1.75 | 1.88 | 1.73 | 2.34 | 2.59 | 1.1 | Upgrade
|
| Gross Profit | -1 | -0.92 | -1.12 | -1.53 | -1.9 | -0.4 | Upgrade
|
| Selling, General & Admin | 8.2 | 7.19 | 7.82 | 7.79 | 8.69 | 6.01 | Upgrade
|
| Research & Development | 10.14 | 8.18 | 7.92 | 7.95 | 9.68 | 5.55 | Upgrade
|
| Operating Expenses | 18.35 | 15.37 | 15.74 | 15.73 | 18.36 | 11.56 | Upgrade
|
| Operating Income | -19.35 | -16.3 | -16.86 | -17.26 | -20.26 | -11.96 | Upgrade
|
| Interest Expense | -0.02 | -0.02 | -0.05 | -0.18 | -0.11 | -0.3 | Upgrade
|
| Interest & Investment Income | 0.71 | 0.26 | 0.06 | 0.11 | 0.02 | 0.03 | Upgrade
|
| Currency Exchange Gain (Loss) | 1.35 | 0.2 | 0.01 | -0.02 | -0.04 | -0.2 | Upgrade
|
| Other Non Operating Income (Expenses) | -18.67 | -13.83 | -5.79 | -0.01 | -0.1 | -0.02 | Upgrade
|
| EBT Excluding Unusual Items | -35.98 | -29.69 | -22.63 | -17.36 | -20.49 | -12.45 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.76 | - | Upgrade
|
| Pretax Income | -35.98 | -29.69 | -22.63 | -17.36 | -19.73 | -12.45 | Upgrade
|
| Net Income | -35.98 | -29.69 | -22.63 | -17.36 | -19.73 | -12.45 | Upgrade
|
| Net Income to Common | -35.98 | -29.69 | -22.63 | -17.36 | -19.73 | -12.45 | Upgrade
|
| Shares Outstanding (Basic) | 277 | 224 | 157 | 146 | 131 | 110 | Upgrade
|
| Shares Outstanding (Diluted) | 277 | 224 | 157 | 146 | 131 | 110 | Upgrade
|
| Shares Change (YoY) | 57.17% | 43.03% | 7.46% | 11.42% | 18.76% | 81.97% | Upgrade
|
| EPS (Basic) | -0.13 | -0.13 | -0.14 | -0.12 | -0.15 | -0.11 | Upgrade
|
| EPS (Diluted) | -0.13 | -0.13 | -0.14 | -0.12 | -0.15 | -0.11 | Upgrade
|
| Free Cash Flow | -16.95 | -15.65 | -13.06 | -16.75 | -18.11 | -12.97 | Upgrade
|
| Free Cash Flow Per Share | -0.06 | -0.07 | -0.08 | -0.12 | -0.14 | -0.12 | Upgrade
|
| Gross Margin | -133.44% | -96.32% | -181.27% | -187.10% | -272.30% | -56.64% | Upgrade
|
| Operating Margin | -2584.69% | -1698.60% | -2738.12% | -2115.18% | -2909.72% | -1702.78% | Upgrade
|
| Profit Margin | -4806.13% | -3094.86% | -3675.61% | -2126.96% | -2834.05% | -1772.60% | Upgrade
|
| Free Cash Flow Margin | -2264.74% | -1631.38% | -2121.66% | -2052.56% | -2601.63% | -1847.52% | Upgrade
|
| EBITDA | -18.61 | -15.55 | -16.15 | -16.55 | -19.57 | -11.43 | Upgrade
|
| D&A For EBITDA | 0.74 | 0.75 | 0.71 | 0.71 | 0.69 | 0.53 | Upgrade
|
| EBIT | -19.35 | -16.3 | -16.86 | -17.26 | -20.26 | -11.96 | Upgrade
|
| Revenue as Reported | 0.75 | 0.96 | 0.62 | 0.82 | 0.7 | 0.7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.